Edison International Common Stock vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Edison International Common Stock trades at $54.43 (market cap $20.94B), while Iovance Biotherapeutics Inc. Common Stock trades at $13.36 (market cap $5.85B). The key difference: Edison International Common Stock is far larger — about 3.6× Iovance Biotherapeutics Inc. Common Stock's market cap, and Edison International Common Stock pays a 6.45% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edison International Common Stock for 0 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| EIX | IOVA | |
|---|---|---|
Market Cap | $20.94B | $5.85B |
Volume | 4,419,339 | 14,517,176 |
Sector | Utilities | Health |
52-Week High | $80.38 | $14.82 |
52-Week Low | $51.47 | $1.81 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $64.32B | $5.78B |
Dividend Yield | 6.45% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Edison International is the parent company of Southern California Edison, an electric utility that supplies and delivers electricity across Southern California. It also owns Trio, an energy advisory business.
Read more on EIX →Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →